The UK government is creating a new £1 billion public-private partnership in life sciences. British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funnelling £200 million to “specialist funds”. Details are thin, but the funds will likely help build up the U.K.'s biotech base, as well as medtech and AI. Source: Fierce Biotech 8/7/2021